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Demonstration of IgG subclass (IgG1 and IgG3) 
in patients with positive direct antiglobulin 
tests
A. Singh, A. Solanki, and R. Chaudhary
Serologic characterization of autoantibodies helps in the 
management and monitoring of the course of autoimmune 
hemolytic anemia (AIHA). The purpose of this study was to 
evaluate gel centrifugation test (GCT) cards for immunoglobulin 
G (IgG) titer and determination of IgG subclasses IgG1 and IgG3 
and their influence on hemolysis. Eighty direct antiglobulin test 
(DAT)-positive patients were examined with the help of GCT 
cards for IgG titer and IgG subclasses. The results were correlated 
with the presence and absence of hemolysis. A statistically 
significant (p < 0.005) association of hemolysis with increasing 
anti-IgG titer was observed. When IgG titer was 30 or less, 28 
(50.91%) patients had no hemolysis, whereas 15 (93.75%) patients 
had features of hemolysis when titer was at least 300. Statistically 
significant (p < 0.005) association of subclass of IgG (IgG1, IgG3) 
coating the red blood cells with intravascular hemolysis was also 
seen. Twenty-nine (80.56%) patients had evidence of hemolysis 
when IgG1 or IgG1-IgG3 both were present. Gel technology is 
helpful to demonstrate red blood cell–bound autoantibodies 
and their characterization with regard to class, subclass, and 
titer. This information is useful to identify patients with AIHA 
who are at risk of severe hemolysis with adverse prognosis. 
Immunohematology 2014;30:24–27.
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Autoimmune hemolytic anemia (AIHA) is characterized 
by increased red blood cell (RBC) destruction or decreased 
RBC survival as a result of autoantibodies directed against 
self-antigen on RBCs.1 The degree of hemolysis depends on 
characteristics of the bound antibody as well as the target 
antigen. Immunoglobulin M (IgM) antibodies readily activate 
the classical complement pathway and produce cytolysis. 
IgG antibodies are relatively poor activators of the classical 
complement pathway but are easily recognized by phagocytic 
cells.2–4 IgG subclasses have a varying affinity for Fc receptors, 
with IgG3 having a higher affinity for mononuclear phagocytes. 
Therefore, monocyte reactions with IgG3 are much more rapid, 
requiring few molecules for initiation of erythrophagocytosis 
and thus having greater potential for RBC destruction.
RBC-bound Ig can be detected using conventional tube 
technique, gel technique, flow cytometry (FC), or capillary 
electrophoresis.5 The tube agglutination assay has been the 
standard antibody detection method for RBC serology tests 
for decades; however, use of the gel microcolumn antibody 
detection system is growing and can be used in place of the tube 
agglutination assay. Gel technology, which was introduced by 
Lapierre et al. in 1990,6 is used to determine ABO group and D 
type,6,7 detect unexpected serum antibodies,8–14 and perform 
the direct antiglobulin test (DAT).15 Compared with the tube 
agglutination assay, the gel microcolumn assay requires less 
test sample and reagent, is easier to read, needs no washing, 
and is more readily automated.15 Although FC is a very 
sensitive method and can detect very small amounts of Ig 
molecules coating the RBCs, it has the disadvantage of being 
costly and not easily available in many of the hospital-based 
blood transfusion services in developing countries.
Here we discuss our experience of gel technology to 
demonstrate IgG subclasses (IgG1 and IgG3) in DAT+ cases 
and their correlation with hemolysis.
Materials and Methods
The study was conducted in the immunohematology 
laboratory of the Department of Transfusion Medicine, 
Sanjay Gandhi Postgraduate Institute of Medical Sciences, 
Lucknow, India, from January 2009 to June 2012. 
Ethylenediaminetetraacetic acid (EDTA) whole blood samples 
from 80 DAT+ patients were tested for IgG subclasses using 
gel technology (Diamed, Cressier, Switzerland). Normal blood 
donors were not included in this retrospective study, which 
was a limitation of this study.
Hemolysis in a patient was documented when at least 
three of the following laboratory parameters were abnormal: 
(1) hemoglobin (Hb; <9 g/dL), (2) percentage of reticulocytes 
(>2%), (3) total serum bilirubin (>2 mg/dL), and (4) lactate 
dehydrogenase (LDH; >500 IU/mL).16
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Gel Technology
For quantification and IgG subclass determination, three 
types of gel centrifugation test (GCT) dilution cards were used. 
The first type (IgG dilution cards) contained dilutions of rabbit 
anti-human polyclonal anti–IgG-g-chain serum of 1 in 10, 1 
in 30, 1 in 100, 1 in 300, and 1 in 1000 and a negative diluent 
control. The second type contained monospecific AHG (ID-
Card DC Screening I, Diamed). This card consisted of five 
different monospecific AHG reagents to anti-IgG, anti-IgA, 
anti-IgM, anti-C3c (all rabbit), and anti-C3d (monoclonal cell 
line C139-9). If antibody was IgG in nature, then the subclass 
was determined by a third type of monospecific anti-IgG1 and 
anti-IgG3 gel card (ID-Card DAT IgG1/IgG3, Diamed). This 
card consisted of monoclonal anti-IgG1 (cell line M345/795) 
in two different dilutions (1:1 and 1:100), anti-IgG3 (cell line 
M346/805) in two different dilutions (1:1 and 1:100), anti-IgG 
1:10 (rabbit), and a negative control. The tests were performed 
following the department’s standard operating procedure 
manual as described previously.17
Elution
To confirm that the positive DAT result is caused by an 
autoantibody, cold acid elution was performed.18 The eluate 
was tested with a three-cell screening panel, ID DiaCell I-II-
III (Diamed), by indirect antiglobulin test using gel cards.
Statistical Analysis
Data were entered in Microsoft Office Excel (Microsoft 
Corporation, Redmond, WA) and analyzed with Statistical 
Package for the Social Sciences (SPSS) version 16.0 (SPSS, Inc., 
Chicago, IL). Pearson’s χ2 test was used to analyze the relations 
between IgG titer with hemolysis and IgG subclass with 
hemolysis. Probability values less than 0.05 were considered 
significant.
Results
A total of 80 DAT+ samples were evaluated. The median 
age of patients was 32.5 years, and the female-to-male ratio 
was 2.33. Of the 80 patients, 49 had features of hemolysis as 
shown in Fig. 1. The median levels of Hb, reticulocyte count, 
total serum bilirubin, and LDH were 6.9 g/dL (range, 3–14.3 
g/dL), 4.7 percent (range, 0.4–41%), 1.35 mg/dL (range, 0.3–
22.7 mg/dL), and 847.5 IU/mL (range, 125–9620 IU/mL), 
respectively.
A statistically significant (p < 0.005) association of 
hemolysis with increasing anti-IgG titer was observed (Fig. 
1). When anti-IgG titer was 30 or less, 27 (49.09%) patients 
had evidence of hemolysis. Similarly, 77.78 percent and 93.75 
percent of the patients experienced hemolysis when anti-IgG 
titer was 100 and at least 300, respectively.
There was a statistically significant (p < 0.005) 
association of subclass of IgG (IgG1, IgG3) coating the RBCs 
with intravascular hemolysis. Of 80 DAT+ samples, 25 had 
IgG1 and 11 had both IgG1 and IgG3, of which 20 (80.0%) 
and 9 (81.82%) had evidence of hemolysis, respectively. In 44 
patients, IgG1 or both IgG1 and IgG3 were not detected; of 
these, 24 (54.55%) had no hemolysis (Table 1).
Whenever DAT was more than 2+ in strength, cold acid 
elution was performed. Eluate was tested with reagent RBC 
panels (Diamed). It was found to be pan-reactive in all the 
samples, confirming the presence of autoantibodies.
Discussion
Introduction of specialized gel cards, such as monospecific 
Ig cards, IgG subclass cards, and IgG dilution cards, have 
made it possible to characterize RBC-bound antibodies in a 
simplified and rapid way. These detailed investigations help 
predict the severity of hemolysis and disease outcome and 























Fig. 1 Correlation of IgG titer with in vivo hemolysis.
Table 1. Correlation of IgG subclass with hemolysis
IgG subclass
Number  
of patients Hemolysis No hemolysis
IgG1 25 20 (80.00%) 5 (20.00%)
IgG1 and IgG3 11 9 (81.82%) 2 (18.18%)
IgG3 only or neither IgG1  
nor IgG3 detected 
44 20 (45.45%) 24 (54.55%)
Total 80 49 (61.25%) 31 (38.75%)
p value <0.005.
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In this study, we demonstrated IgG subclasses (IgG1 and 
IgG3) in DAT+ patients using specialized gel cards (Diamed). 
IgG2 and IgG4 were not studied, as these are rare antibodies 
involved in AIHA; moreover, Diamed does not provide gel 
cards for detection of these subclasses. IgG1 or both IgG1 and 
IgG3 were observed with hemolysis in 29 (59.18%) patients. 
This finding was almost the same as that of Das et al.16 They 
reported IgG subclasses, IgG1 or IgG3 or both, coating the 
RBC membrane in 46.5 percent of their DAT+ patients with 
AIHA. We have observed a statistically significant association 
of IgG1 and IgG3 with intravascular hemolysis (Table 1, 
Fig. 2). This result is in agreement with previous studies.19,20 
Garratty21 found that most of the RBC-bound IgG was of 
the IgG1 subclass similar to our study, but did not find any 
correlation with the quantity of RBC-bound IgG and the rate 
of in vivo RBC destruction.
One factor that possibly contributes to the degree of 
hemolysis is the IgG subclass. Four human subclasses of 
the IgG molecule can be differentiated (IgG1, IgG2, IgG3, 
and IgG4) of which IgG1 is predominant. Although all four 
subclasses are able to induce hemolysis, types 1 and 3 bind to 
the Fc receptor of phagocytic cells with greater affinity than 
do types 2 and 4. Hemolysis is therefore expected to occur to a 
greater extent in association with the former.22
The extent of RBC destruction depends not only on the 
density of the cell-bound antibodies and the IgG subclass, but 
also on the type of effector cells, the Fc receptors of the latter, 
and complement activation. Immune hemolysis also depends 
on other factors influencing the activity of the monocyte/
macrophage system, on the kind and stage of underlying 
disease, or on therapeutic actions.23
We found that increasing the titer of IgG was significantly 
associated with hemolysis. When titer was at least 300, 15 of 16 
(93.75%) patients had features of hemolysis. Lai et al.24 found 
in their study that in 81 percent of AIHA patients, the IgG titer 
was at least 300; however, they reported a strong association 
of DAT strength with hemolysis compared with anti-IgG titer. 
Lynen et al.20 reported that immune hemolysis is unlikely if the 
titer is 30 or less, whereas immune mechanisms are probably 
the cause of hemolysis if the titer is at least 300. Although 
there is a correlation between the amount of immunoglobulin 
molecules coating the RBCs and in vivo hemolysis, the actual 
threshold required to induce hemolysis is not exactly known.
There are several methods of quantitative determination 
of IgG subclasses of antibodies.25 In general, they are very 
useful, especially for a better understanding of immune RBC 
destruction, but for routine use, they are not very practical. 
The simplicity of GCT, as it requires less test sample and 
reagent, is easier to read, needs no washing, and achieves a 
stable agglutination that allows reading the result over a long 
period, makes it very useful in practice.
We have used gel technology for demonstration of IgG 
subclasses on DAT+ RBCs. Flow cytometry has been used 
by some workers20 to demonstrate IgG subclasses on RBC 
membranes, as it is more precise and reproducible than 
standard techniques. In addition, FC can actually quantitate 
the number of IgG subclass molecules on RBC membranes.20 
However, FC may not actually be useful in predicting 
hemolysis.
Although blood samples from donors were not included in 
this study, the testing performed on referred patient samples 
illustrated that gel technology is helpful to demonstrate RBC-
bound autoantibodies and their characterization with regard 
to class, subclass, and titer. This information is useful to 
identify patients of AIHA who are at risk of severe hemolysis 
with adverse prognosis.
Fig. 2 Correlation of IgG subclass (G1 or G3) with various hemolytic 
parameters: (A) hemoglobin (Hb), (B) reticulocyte count (Retic), 
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